Hence, these results indicate that H. erinaceus mycelia could be an attractive agent for the treatment of depressive disorders through the modulation of monoamine neurotransmitters and proinflammatory cytokines as well as the regulation of brain-derived neurotrophic factor (BDNF) pathways. This evidence concerns the gene BDNF and depressive disorder.